RHYTHM PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-32.3M | $-141.4M | $-41.6M | $-44.2M | $-46.7M | $-52.2M | $-42.5M | $-40.9M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | $214.0K | $214.0K | $214.0K |
| Stock-Based Compensation | $10.4M | $7.8M | $8.7M | $8.6M | $8.9M | $6.4M | $5.3M | $4.8M |
| Net Cash from Operating Activities | $-29.1M | $-40.7M | $-29.4M | $-29.3M | $-41.1M | $-36.4M | $-34.0M | $-47.0M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $-1.0K | $1.0K | $0 | $47.0K | $-1.0K | $95.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-8.6M | $30.1M | $22.6M | $-95.0M | $48.2M | $18.5M | $-40.8M | $-39.7M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $146.2M | $4.2M | $2.4M | $73.0M | $-965.0K | $-133.0K | $17.4M | $158.6M |
| Net Change in Cash | $108.2M | $-6.5M | $-4.5M | $-51.1M | $6.0M | $-18.0M | $-57.4M | $71.9M |
| Free Cash Flow | — | — | $-29.4M | $-29.3M | $-41.1M | $-36.5M | $-34.0M | $-47.1M |